Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eastman

Showing results (131-140 of 1,740) with videos related to

Pageof 174
Sort By:
Clinical Genetics|June 1, 1977
Facio-cardio-renal syndrome: a newly delineated recessive disorderJ R Eastman, D Bixler
Experimental Cell Research|March 6, 1999
The temporal relationship between protein phosphatase, mitochondrial cytochrome c release, and caspase activation in apoptosisC M Wolf, A Eastman
The Medical Journal of Australia|December 21, 2002
Working with funding agencies in the delivery of healthcare in the Asia Pacific regionMu Li, Creswell J Eastman
The Australian Journal of Experimental Biology and Medical Science|August 1, 1981
The erythrocyte insulin receptorA McElduff, C J Eastman
British Journal of Clinical Pharmacology|July 18, 2006
New targets and challenges in the molecular therapeutics of cancerAlan Eastman, Raymond P Perez
Nucleic Acids Research|November 25, 1991
A polymerase chain reaction-based method to detect cisplatin adducts in specific genesM M Jennerwein, A Eastman
Biochemical and Biophysical Research Communications|January 28, 1999
Intracellular acidification during apoptosis can occur in the absence of a nucleusC M Wolf, A Eastman
Cancers|August 23, 2020
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXADavid J Mallick, Alan Eastman
Cancer Biology & Therapy|July 25, 2012
Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implicationsLi-Ju Chang, Alan Eastman
ACS Pharmacology & Translational Science|April 16, 2021
Comparative Activity and Off-Target Effects in Cells of the CHK1 Inhibitors MK-8776, SRA737, and LY2606368Jennifer P Ditano, Alan Eastman
Pageof 174

Showing results (131-140 of 1,740) with videos related to

Sort By:
Pageof 174
Clinical Genetics|June 1, 1977
Facio-cardio-renal syndrome: a newly delineated recessive disorderJ R Eastman, D Bixler
Experimental Cell Research|March 6, 1999
The temporal relationship between protein phosphatase, mitochondrial cytochrome c release, and caspase activation in apoptosisC M Wolf, A Eastman
The Medical Journal of Australia|December 21, 2002
Working with funding agencies in the delivery of healthcare in the Asia Pacific regionMu Li, Creswell J Eastman
The Australian Journal of Experimental Biology and Medical Science|August 1, 1981
The erythrocyte insulin receptorA McElduff, C J Eastman
British Journal of Clinical Pharmacology|July 18, 2006
New targets and challenges in the molecular therapeutics of cancerAlan Eastman, Raymond P Perez
Nucleic Acids Research|November 25, 1991
A polymerase chain reaction-based method to detect cisplatin adducts in specific genesM M Jennerwein, A Eastman
Biochemical and Biophysical Research Communications|January 28, 1999
Intracellular acidification during apoptosis can occur in the absence of a nucleusC M Wolf, A Eastman
Cancers|August 23, 2020
AT101 [(-)-Gossypol] Selectively Inhibits MCL1 and Sensitizes Carcinoma to BH3 Mimetics by Inducing and Stabilizing NOXADavid J Mallick, Alan Eastman
Cancer Biology & Therapy|July 25, 2012
Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implicationsLi-Ju Chang, Alan Eastman
ACS Pharmacology & Translational Science|April 16, 2021
Comparative Activity and Off-Target Effects in Cells of the CHK1 Inhibitors MK-8776, SRA737, and LY2606368Jennifer P Ditano, Alan Eastman
Pageof 174